Coriolan Lebreton
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 6
Publications (10 Years): 6
Publications
- Antonio Gonzáles Martin, María Jesús Rubio, Florian Heitz, René Depont Christensen, Nicoletta Colombo, Toon Van Gorp, Margarita Romeo Marin, Isabelle L Ray-Coquard, Lydia Gaba, Alexandra Leary, Luis Miguel De Sande, Coriolan Lebreton, Andrés Redondo, Michel Fabbro, Maria-Pilar Barretina Ginesta, Philippe Follana, José Alejandro Pérez-Fidalgo, Manuel J Rodrigues, Ana Santaballa, Renaud Sabatier, Maria José Bermejo-Pérez, Jean-Pierre Lotz, Beatriz Pardo, Gloria Marquina, Luisa Sanchez Lorenzo, María Quindós, Purificación Estévez-García, Eva Guerra Alía, Luis Manso Sanchez, Victoria Casado, Stefan Kommoss, Germana Tognon, Stéphanie Henry, Ilan Bruchim, Ana Oaknin, Frédéric Selle
- Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Pia Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine J Nøttrup, Coriolan Lebreton, Peter A Fasching, Carmela Pisano, Luis Manso, Hugues Bourgeois, Ingo Runnebaum, Claudio Zamagni, Anne-Claire Hardy-Bessard, Andreas Schnelzer, Michel Fabbro, Barbara Schmalfeldt, Dominique Berton, Antje Belau, Jean-Pierre Lotz, Martina Gropp-Meier, Laurence Gladieff, Hans-Joachim Lück, Sophie Abadie-Lacourtoisie, Eric Pujade-Lauraine, Isabelle L Ray-CoquardUpdated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
- Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Pia Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine J Nøttrup, Coriolan Lebreton, Peter A Fasching, Carmela Pisano, Luis Manso, Hugues Bourgeois, Ingo Runnebaum, Claudio Zamagni, Anne-Claire Hardy-Bessard, Andreas Schnelzer, Michel Fabbro, Barbara Schmalfeldt, Dominique Berton, Antje Belau, Jean-Pierre Lotz, Martina Gropp-Meier, Laurence Gladieff, Hans-Joachim Lück, Sophie Abadie-Lacourtoisie, Eric Pujade-Lauraine, Isabelle L Ray-CoquardUpdated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
- Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Pia Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine J Nøttrup, Coriolan Lebreton, Peter A Fasching, Carmela Pisano, Luis Manso, Hugues Bourgeois, Ingo Runnebaum, Claudio Zamagni, Anne-Claire Hardy-Bessard, Andreas Schnelzer, Michel Fabbro, Barbara Schmalfeldt, Dominique Berton, Antje Belau, Jean-Pierre Lotz, Martina Gropp-Meier, Laurence Gladieff, Hans-Joachim Lück, Sophie Abadie-Lacourtoisie, Eric Pujade-Lauraine, Isabelle L Ray-CoquardUpdated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
- Jean-Emmanuel Kurtz, Eric Pujade-Lauraine, Ana Oaknin, Lisa Belin, Katharina Leitner, David Cibula, Hannelore G Denys, Ora Rosengarten, Manuel J Rodrigues, Nikolaus de Gregorio, Jerónimo Martínez-Garcia, Edgar Petru, Roman Kocian, Ignace Vergote, Patricia Pautier, Barbara Schmalfeldt, Lydia Gaba, Stephan Polterauer, Marie-Ange Mouret Reynier, Jalid Sehouli, Cristina Churruca, Frédéric Selle, Florence Joly Lobbedez, Veronique D'Hondt, Émilie Bultot-Boissier, Coriolan Lebreton, Jean-Pierre Lotz, Rémy Largillier, Pierre Etienne Heudel, Florian Heitz, null null
- Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Pia Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine J Nøttrup, Coriolan Lebreton, Peter A Fasching, Carmela Pisano, Luis Manso, Hugues Bourgeois, Ingo Runnebaum, Claudio Zamagni, Anne-Claire Hardy-Bessard, Andreas Schnelzer, Michel Fabbro, Barbara Schmalfeldt, Dominique Berton, Antje Belau, Jean-Pierre Lotz, Martina Gropp-Meier, Laurence Gladieff, Hans-Joachim Lück, Sophie Abadie-Lacourtoisie, Eric Pujade-Lauraine, Isabelle L Ray-CoquardUpdated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)